The DOI matches its Crossref record; 42 of the 42 references it cites were found in a registry or an index.
The TyG index may predict the development of cardiovascular events
Abstract
Background: Cardiovascular disease (CVD) is the worldwide leading cause of morbidity and mortality. An early risk detection of apparently healthy people before CVD onset has clinical relevance in the prevention of cardiovascular events. We evaluated the association between the product of fasting plasma glucose and triglycerides (TyG index) and CVD. Material and methods: A total of 5014 patients of the Vascular Metabolic CUN cohort (VMCUN cohort) were followed up during a median period of 10 years. We used a Cox proportional‐hazard ratio with repeated measures to estimate the risk of incidence of CVD across quintiles of the TyG index, calculated as ln[fasting triglycerides (mg/dL) × fasting plasma glucose (mg(dL)/2], and plotted a receiver‐operating characteristics (ROC) curve to compare a prediction model fitted on the variables used in the Framingham risk score, a new model containing the Framingham variables with the TyG index, and the risk of coronary heart disease. Results: A higher level of TyG index was significantly associated with an increased risk of developing CVD independent of confounding factors with a value of 2·32 (95% CI: 1·65–3·26) for those in the highest quintile and 1·52 (95% CI: 1·07–2·16) for those in the fourth quintile. The areas under the curve (AUC) of the ROC plots were 0·708 (0·68–0·73) for the Framingham model and 0·719 (0·70–0·74) for the Framingham + TyG index model (P = 0·014). Conclusions: The TyG index, a simple measure reflecting insulin resistance, might be useful to early identify individuals at a high risk of developing a cardiovascular event.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
RETRACTED: Primary Prevention of Cardiovascular Disease with a Mediterranean Diet
Estruch, R., Ros, E., Salas-Salvadó, J., Covas, M.-I., Corella, D., Arós, F., Gómez-Gracia, E., Ruiz-Gutiérrez, V., Fiol, M., Lapetra, J., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1200303 · Cited by 4,257
Self-citationRetractedDetection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III)
Grundy, S. M., Becker, D. M., Clark, L. T., Cooper, R., Denke, M. A., Howard, J. L., Hunninghake, D. B., Illingworth, D. R., Luepker, R. V., McBride, P. E., et al. (2002) · Civil War Book Review · Cited by 12,198
Prediction of coronary heart disease using risk factor categories
Wilson, P. W. F., D’Agostino, R. B., Levy, D., Belanger, A. M., Silbershatz, H., & Kannel, W. B. (1998) · Circulation · doi:10.1161/01.cir.97.18.1837 · Cited by 9,581
(1999) · Journal of Hypertension · doi:10.1097/00004872-199917020-00001 · Cited by 3,695
Explaining the decrease in U.S. deaths from coronary disease, 1980–2000
Ford, E. S., Ajani, U. A., Croft, J. B., Critchley, J. A., Labarthe, D. R., Kottke, T. E., Giles, W. H., & Capewell, S. (2007) · New England Journal of Medicine · doi:10.1056/nejmsa053935 · Cited by 2,757
Major lipids, apolipoproteins, and risk of vascular disease
The Emerging Risk Factors Collaboration* (2009) · JAMA · doi:10.1001/jama.2009.1619 · Cited by 2,731
Simental-Mendía, L. E., Rodríguez-Morán, M., & Guerrero-Romero, F. (2008) · Metabolic Syndrome and Related Disorders · doi:10.1089/met.2008.0034 · Cited by 2,445
Guerrero-Romero, F., Simental-Mendía, L. E., González-Ortiz, M., Martínez-Abundis, E., Ramos-Zavala, M. G., Hernández-González, S. O., Jacques-Camarena, O., & Rodríguez-Morán, M. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2010-0288 · Cited by 2,247
D'Agostino, R. B., Grundy, S., Sullivan, L. M., Wilson, P., & for the CHD Risk Prediction Group (2001) · JAMA · doi:10.1001/jama.286.2.180 · Cited by 2,108
Dose‐response analyses using restricted cubic spline functions in public health research
Desquilbet, L., & Mariotti, F. (2010) · Statistics in Medicine · doi:10.1002/sim.3841 · Cited by 1,980
Triglycerides and Cardiovascular Disease: A Scientific Statement From the American Heart Association
Miller, M., Stone, N. J., Ballantyne, C., Bittner, V., Criqui, M. H., Ginsberg, H. N., Goldberg, A. C., Howard, W. J., Jacobson, M. S., Kris-Etherton, P. M., et al. (2011) · Circulation · doi:10.1161/cir.0b013e3182160726 · Cited by 1,871
Chapman, M. J., Ginsberg, H. N., Amarenco, P., Andreotti, F., Borén, J., Catapano, A. L., Descamps, O. S., Fisher, E., Kovanen, P. T., Kuivenhoven, J. A., et al. (2011) · European Heart Journal · doi:10.1093/eurheartj/ehr112 · Cited by 1,227
Disordered lipid metabolism and the pathogenesis of insulin resistance.
Savage, D. B., Petersen, K. F., & Shulman, G. I. (2007) · Physiological Reviews · doi:10.1152/physrev.00024.2006 · Cited by 1,107
Hypertriglyceridemia as a cardiovascular risk factor
Austin, M. A., Hokanson, J. E., & Edwards, K. L. (1998) · The American Journal of Cardiology · doi:10.1016/s0002-9149(98)00031-9 · Cited by 1,066
Clinical Practice Recommendations
Fowler, M. J. (2011) · Clinical Diabetes · doi:10.2337/diaclin.29.4.163 · Cited by 995
TyG index performs better than HOMA in a Brazilian population: A hyperglycemic clamp validated study
Vasques, A. C. J., Novaes, F. S., de Oliveira, M. D. S., Matos Souza, J. R., Yamanaka, A., Pareja, J. C., Tambascia, M. A., Saad, M. J. A., & Geloneze, B. (2011) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2011.05.030 · Cited by 795
Du, T., Yuan, G., Zhang, M., Zhou, X., Sun, X., & Yu, X. (2014) · Cardiovascular Diabetology · doi:10.1186/preaccept-1207347889137599 · Cited by 620
Clinical Practice Recommendations
Fowler, M. J. (2009) · Clinical Diabetes · doi:10.2337/diaclin.27.4.160 · Cited by 365
Assessment of Claims of Improved Prediction Beyond the Framingham Risk Score
Tzoulaki, I. (2009) · JAMA · doi:10.1001/jama.2009.1757 · Cited by 276
Lee, S.-H., Kwon, H.-S., Park, Y.-M., Ha, H.-S., Jeong, S. H., Yang, H. K., Lee, J.-H., Yim, H.-W., Kang, M.-I., Lee, W.-C., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0090430 · Cited by 275
Schwartz, G. G., Abt, M., Bao, W., DeMicco, D., Kallend, D., Miller, M., Mundl, H., & Olsson, A. G. (2015) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2015.03.544 · Cited by 272
Abbasi, F., & Reaven, G. M. (2011) · Metabolism · doi:10.1016/j.metabol.2011.04.006 · Cited by 240
Siegel, R. D., Cupples, A., Schaefer, E. J., & Wilson, P. W. F. (1996) · Metabolism · doi:10.1016/s0026-0495(96)90246-2 · Cited by 176
Relationship between Serum Lipoprotein Ratios and Insulin Resistance in Obesity
Brehm, A., Pfeiler, G., Pacini, G., Vierhapper, H., & Roden, M. (2004) · Clinical Chemistry · doi:10.1373/clinchem.2004.037556 · Cited by 167
The DECODE Insulin Study Group (2004) · Diabetologia · doi:10.1007/s00125-004-1433-4 · Cited by 161
The Framingham Heart Study's Impact on Global Risk Assessment
Bitton, A., & Gaziano, T. (2010) · Progress in Cardiovascular Diseases · doi:10.1016/j.pcad.2010.04.001 · Cited by 158
Backer, G. D., Besseling, J., Chapman, J., Hovingh, G. K., Kastelein, J. J. P., Kotseva, K., Ray, K. K., Reiner, Ž., Wood, D., & Bacquer, D. D. (2015) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2015.04.809 · Cited by 155
Insulin Action in the Vasculature: Physiology and Pathophysiology
Mather, K. J., Anderson, T. J., & Verma, S. (2001) · Journal of Vascular Research · doi:10.1159/000051074 · Cited by 123
Update on the NCEP ATP-III emerging cardiometabolic risk factors
Eckel, R. H., & Cornier, M. (2014) · BMC Medicine · doi:10.1186/1741-7015-12-115 · Cited by 96
Lee, S., Han, K., Yang, H. K., Kim, M. K., Yoon, K., Kwon, H., & Park, Y. (2014) · Clinical Endocrinology · doi:10.1111/cen.12502 · Cited by 83
Onat, A., Sarı, İ., Yazıcı, M., Can, G., Hergenç, G., & Avcı, G. Ş. (2005) · International Journal of Cardiology · doi:10.1016/j.ijcard.2005.06.056 · Cited by 77
Changes in Metabolic Health Status Over Time and Risk of Developing Type 2 Diabetes
Lee, S., Yang, H. K., Ha, H., Lee, J., Kwon, H., Park, Y., Yim, H., Kang, M., Lee, W., Son, H., et al. (2015) · Medicine · doi:10.1097/md.0000000000001705 · Cited by 60
Park, J. S., Cho, M. H., Ahn, C. W., Kim, K. R., & Huh, K. B. (2012) · Cardiovascular Diabetology · doi:10.1186/1475-2840-11-62 · Cited by 49
Miselli, M. A., Nora, E. D., Passaro, A., Tomasi, F., & Zuliani, G. (2014) · Cardiovascular Diabetology · doi:10.1186/s12933-014-0135-6 · Cited by 45
Optimal Management of Combined Dyslipidemia: What Have We Behind Statins Monotherapy?
Tenenbaum, A., Fisman, E. Z., Motro, M., & Adler, Y. (2008) · Advances in cardiology · doi:10.1159/000115192 · Cited by 38
Abate, N. I. (1995) · Atherosclerosis · doi:10.1016/0021-9150(95)05597-p · Cited by 31
Serum Triglyceride Levels and Cardiovascular Disease Events in Koreans
Kim, E. H., Lee, J. B., Kim, S., Jo, M., Hwang, J. Y., Bae, S. J., Jung, C. H., Lee, W. J., Park, J., Park, G., et al. (2015) · Cardiology · doi:10.1159/000380941 · Cited by 30
Shimodaira, M., Niwa, T., Nakajima, K., Kobayashi, M., Hanyu, N., & Nakayama, T. (2014) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2014.38.4.294 · Cited by 18
Triglyceride Glucose Index and Common Carotid Wall Shear Stress
Tripolino, C., Irace, C., Scavelli, F. B., Franceschi, M. S. D., Esposito, T., Carallo, C., & Gnasso, A. (2014) · Journal of Investigative Medicine · doi:10.2310/jim.0000000000000043 · Cited by 17
Cited by
Triglyceride-glucose index as a marker in cardiovascular diseases: landscape and limitations
Tao, L.-C., Xu, J.-N., Wang, T.-T., Hua, F., & Li, J.-J. (2022) · Cardiovascular Diabetology · doi:10.1186/s12933-022-01511-x · Cited by 1,042
Dang, K., Wang, X., Hu, J., Zhang, Y., Cheng, L., Qi, X., Liu, L., Ming, Z., Tao, X., & Li, Y. (2024) · Cardiovascular Diabetology · doi:10.1186/s12933-023-02115-9 · Cited by 599
Ding, X., Wang, X., Wu, J., Zhang, M., & Cui, M. (2021) · Cardiovascular Diabetology · doi:10.1186/s12933-021-01268-9 · Cited by 454
Wang, L., Cong, H.-L., Zhang, J.-X., Hu, Y.-C., Wei, A., Zhang, Y.-Y., Yang, H., Ren, L.-B., Qi, W., Li, W.-Y., et al. (2020) · Cardiovascular Diabetology · doi:10.1186/s12933-020-01054-z · Cited by 435
Liu, X., Tan, Z., Huang, Y., Zhao, H., Liu, M., Yu, P., Ma, J., Zhao, Y., Zhu, W., & Wang, J. (2022) · Cardiovascular Diabetology · doi:10.1186/s12933-022-01546-0 · Cited by 409
Metadata
- Authors
- Sánchez‐Íñigo, L., Navarro‐González, D., Fernández‐Montero, A., Pastrana‐Delgado, J., & Martínez, J. A.
- Venue
- European Journal of Clinical Investigation
- Publisher
- Wiley
- Published
- 2016-01-23
- Volume
- 46
- Issue
- 2
- Pages
- 189-197
- ISSN
- 0014-2972 (ISSN-L)
- 1365-2362
- OpenAlex
- W2217853646
- Cited by
- 663
- References
- 42
- FWCI
- 7.85
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.